STAMBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.872400E-01
Normal-vs-Stage2
5.055800E-01
Normal-vs-Stage3
6.576600E-01
Normal-vs-Stage4
2.915400E-01
Stage1-vs-Stage2
8.544600E-01
Stage1-vs-Stage3
4.476600E-01
Stage1-vs-Stage4
4.152200E-01
Stage2-vs-Stage3
1.971390E-01
Stage2-vs-Stage4
2.024800E-01
Stage3-vs-Stage4
1.841960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.654400E-01
Normal-vs-AfricanAmerican
7.637000E-01
Normal-vs-Asian
7.778800E-01
Caucasian-vs-AfricanAmerican
6.685000E-01
Caucasian-vs-Asian
5.902600E-01
AfricanAmerican-vs-Asian
9.836800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.826600E-01
Normal-vs-Female
5.561600E-01
Male-vs-Female
9.188800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.536400E-01
Normal-vs-Age(41-60Yrs)
3.311000E-01
Normal-vs-Age(61-80Yrs)
7.106600E-01
Normal-vs-Age(81-100Yrs)
3.103800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.614800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.714000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.248800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.157810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.993600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.372400E-01
Normal-vs-Daily Drinker
8.531400E-01
Normal-vs-Weekly Drinker
8.897200E-01
Normal-vs-Occasional Drinker
2.683200E-01
Normal-vs-Social Drinker
6.217200E-01
Non Drinker-vs-Daily Drinker
7.267200E-01
Non Drinker-vs-Weekly Drinker
7.229600E-01
Non Drinker-vs-Occasional Drinker
1.365420E-01
Non Drinker-vs-Social Drinker
9.800800E-01
Daily Drinker-vs-Weekly Drinker
9.527800E-01
Daily Drinker-vs-Occasional Drinker
7.681600E-02
Daily Drinker-vs-Social Drinker
7.482600E-01
Weekly Drinker-vs-Occasional Drinker
1.140200E-01
Weekly Drinker-vs-Social Drinker
7.260000E-01
Occasional Drinker-vs-Social Drinker
1.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.419600E-01
Normal-vs-Grade 2
4.016000E-02
Normal-vs-Grade 3
2.379900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.824000E-03
Grade 1-vs-Grade 3
1.361860E-04
Grade 1-vs-Grade 4
2.419600E-01
Grade 2-vs-Grade 3
4.517800E-02
Grade 2-vs-Grade 4
4.016000E-02
Grade 3-vs-Grade 4
2.379900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.975400E-01
Normal-vs-NonDiabetic
5.574200E-01
Diabetic-vs-NonDiabetic
6.663600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.192200E-02
Normal-vs-NoPancreatitis
6.495000E-01
Pancreatitis-vs-NoPancreatitis
3.006300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.679600E-01
Normal-vs-N1
5.098800E-01
N0-vs-N1
5.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.631900E-02
Normal-vs-TP53-NonMutant
7.893600E-01
TP53-Mutant-vs-TP53-NonMutant
9.7607000004718E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
